Skip to main content
. 2024 Jul 8;184(9):1056–1064. doi: 10.1001/jamainternmed.2024.2525

Figure 1. Study Flow Diagram.

Figure 1.

A complete negative history of glucagon-like peptide 1 receptor agonist (GLP-1 RA) dispensing was required before the index date. Other exclusions include missing sex and no follow-up time. GLP-1 RA refers to both GLP-1 RA and GLP-1 RA/gastric inhibitory polypeptide agonist medications.

aIndex event: first GLP-1 dispensed between May 2022 to September 2023.